Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
May 31, 2000
Study Completion Date
August 31, 2003
Conditions
LeukemiaLung CancerLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesProstate Cancer
Interventions
DRUG
azacitidine
DRUG
sodium phenylbutyrate
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00006019 - Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | Biotech Hunter | Biotech Hunter